Literature DB >> 7751179

The relative biological effectiveness of I-125 and Pd-103.

C C Ling1, W X Li, L L Anderson.   

Abstract

PURPOSE: To determine the relative biological effectiveness (RBE) of I-125 and Pd-103 relative to Co-60. METHODS AND MATERIALS: A cell line REC:ras, derived from rat embryo cells, was used. Cells in exponential or plateau phase were irradiated at dose rates of about 0.07 Gy/h and 0.14 Gy/h. To circumvent the interface effect, cells were grown and irradiated on membranes made of cellulose acetate, which has an effective Z of 7.5. I-125 and Pd-103 seeds were placed in a custom designed template that yielded a homogeneous dose distribution in the plane of the cell culture. The dose rates of irradiation were measured by calibrated thermoluminescence dosimetry (TLD) chips. RESULTS AND
CONCLUSIONS: Our measurements yielded an RBE of about 1.4 for I-125 at dose rates of about 0.07 Gy/h, and an RBE of about 1.9 for Pd-103 at dose rates of about 0.07 Gy/h and 0.14 Gy/h. The RBE of I-125 is similar to those measured by other investigators, the RBE for Pd-103 is being reported for the first time.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7751179     DOI: 10.1016/0360-3016(95)00530-C

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

1.  Comparison of Axxent-Xoft, (192)Ir and (60)Co high-dose-rate brachytherapy sources for image-guided brachytherapy treatment planning for cervical cancer.

Authors:  P N Mobit; S Packianathan; R He; C C Yang
Journal:  Br J Radiol       Date:  2015-05-21       Impact factor: 3.039

2.  Advances in brachytherapy.

Authors:  Peter Grimm; John Sylvester
Journal:  Rev Urol       Date:  2004

Review 3.  Stereotactic Radiation Therapy versus Brachytherapy: Relative Strengths of Two Highly Efficient Options for the Treatment of Localized Prostate Cancer.

Authors:  Manon Kissel; Gilles Créhange; Pierre Graff
Journal:  Cancers (Basel)       Date:  2022-04-29       Impact factor: 6.575

Review 4.  Iodine-125 brachytherapy for brain tumours--a review.

Authors:  Silke B Schwarz; Niklas Thon; Katharina Nikolajek; Maximilian Niyazi; Joerg-Christian Tonn; Claus Belka; Friedrich-Wilhelm Kreth
Journal:  Radiat Oncol       Date:  2012-03-06       Impact factor: 3.481

5.  Radiobiologically based treatment plan evaluation for prostate seed implants.

Authors:  Courtney Knaup; Panayiotis Mavroidis; Carlos Esquivel; Dimos Baltas; Sotirios Stathakis; Gregory Swanson; Nikos Papanikolaou
Journal:  J Contemp Brachytherapy       Date:  2011-07-06

6.  Activation and inactivation of Bacillus pumilus spores by kiloelectron volt X-ray irradiation.

Authors:  Thi Mai Hoa Ha; Derrick Yong; Elizabeth Mei Yin Lee; Prathab Kumar; Yuan Kun Lee; Weibiao Zhou
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

7.  Evaluation of the effect of prostate volume change on tumor control probability in LDR brachytherapy.

Authors:  Courtney Knaup; Panayiotis Mavroidis; Sotirios Stathakis; Mark Smith; Gregory Swanson; Niko Papanikolaou
Journal:  J Contemp Brachytherapy       Date:  2011-09-30

8.  A comparison of the biological effects of 125I seeds continuous low-dose-rate radiation and 60Co high-dose-rate gamma radiation on non-small cell lung cancer cells.

Authors:  Zhongmin Wang; Zhenzhen Zhao; Jian Lu; Zhijin Chen; Aiwu Mao; Gaojun Teng; Fenju Liu
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

9.  The efficacy of iodine-125 permanent brachytherapy versus intensity-modulated radiation for inoperable salivary gland malignancies: study protocol of a randomised controlled trial.

Authors:  Shu-Ming Liu; Hai-Bo Wang; Yan Sun; Yan Shi; Jie Zhang; Ming-Wei Huang; Lei Zheng; Xiao-Ming Lv; Bao-Min Zheng; Kathleen H Reilly; Xiao-Yan Yan; Ping Ji; Yang-Feng Wu; Jian-Guo Zhang
Journal:  BMC Cancer       Date:  2016-03-07       Impact factor: 4.430

10.  Analysis of the relationship between prescribed dose and dosimetric advantage of real-time intraoperatively built custom-linked seeds in iodine-125 prostate brachytherapy.

Authors:  Katsumi Hirose; Masahiko Aoki; Mariko Sato; Hiroyoshi Akimoto; Yasuhiro Hashimoto; Atsushi Imai; Noritaka Kamimura; Hideo Kawaguchi; Yoshiomi Hatayama; Ichitaro Fujioka; Mitsuki Tanaka; Chikara Ohyama; Yoshihiro Takai
Journal:  Radiat Oncol       Date:  2017-12-01       Impact factor: 3.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.